In conjunction with this launch, Neuraly has raise
Post# of 30028
(Total Views: 390)
Posted On: 07/18/2018 9:01:48 PM
In conjunction with this launch, Neuraly has raised a Series A financing of $36 million from holding company, D&D Pharmatech with participation by major Korean venture funds, including: Smilegate Investment, InterVest, LB Investment, MAGNA INVESTMENT, Geon Investment and Dongkoo Bio&Pharma.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼